Identifying mechanisms that underlie the resistance of human melanoma to radiation and chemotherapy is expected to assist in developing new strategies for the treatment of this tumor type. We recently demonstrated that through up-regulation of TNFa, ATF2 increases the resistance of late stage melanoma cells to apoptosis induced by UV-irradiation. In elucidating the role of ATF2 kinases, we now demonstrate that ASK1/MKK6/ p38 elicits suppression of Fas expression. ASK1/p38 downregulates the expression of a Fas via NF-kB/SP1 site on the Fas promoter. Deletion or mutation of NFkB/SP1 within the Fas promoter abrogates p38 eect. ASK1/p38 silences the Fas promoter by inhibition of IkBa phosphorylation ± thereby limiting NF-kB activity. Forced expression of a dominant negative form of p38 (p38-ASP) or treatment with p38 pharmacological inhibitor, SB203580, increases NF-kB activity, Fas expression and the levels of UVC-induced apoptosis in late stage melanoma cells. Inhibition of p38 activity also restored NF-kB activity and Fas expression in earlyphase melanoma cells, suggesting that p38 elicited suppression of Fas expression is not restricted to late phase melanoma. Identifying p38-mediated down-regulation of Fas expression illustrates a novel regulatory pathway by which ASK1/MKK6/p38 alters the degree and nature of the UV-induced apoptosis of melanoma cells.
Introduction
Malignant melanoma, a tumor whose incidence maintains a constant increase in the last decade, responds poorly to chemotherapy and irradiation. The molecular mechanism of melanoma progression and the regulation of apoptosis remains largely unknown (Meier et al., 1998) . In earlier studies we demonstrated the role of the transcription factor ATF2 in the radiation resistance of late-stage LU1205 human melanoma cells Ivanov and Ronai, 1999) . Forced expression of an inactive form of ATF2, in which the amino-terminal transactivation domain was deleted, reduced radiation resistance and augmented UV-induced apoptosis through the silencing of TNFa expression and the increase in the fraction of cells that underwent UV-induced Fas-mediated apoptosis. Conversely, over-expression of full-length ATF2 in the presence of its upstream kinase p38, increased TNFa expression and protection of melanoma cells from UVirradiation (Ivanov and Ronai, 1999) .
ATF2 is activated both by JNK and by p38 stress kinases, which phosphorylate this transcription factor on residues 69 and 71 (Minden and Karin, 1997; Ip and Davis, 1998) . Common to regulation by p38 and JNK, in response to stress and DNA damage, is activation of the upstream components of kinase cascades, ASK1 (Chen et al., 1999; Ichijo et al., 1997) and MEKK1 (Minden and Karin, 1997; Ip and Davis, 1998) , both of which are coordinated by TRAF2 (Yuasa et al., 1998) . TRAF2 is also capable of eliciting negative regulatory signals as illustrated for TNFa expression in TRAF2 null cells (Nguyen et al., 1999) , possibly due to the nature of its interaction with multiple signaling components including NIK, ASK1, GCK and MEKK1.
Compelling evidence supports both a protective and a promoting role of p38 in the regulation of cell death, depending on the cell type and the nature of the stimuli administered, although the mechanisms underlying these changes are not well understood (Xia et al., 1995) . For example, p38 elicits a pro-apoptotic signal in response to UV-B irradiation of human keratinocytes through upregulation of caspases (Shimizu et al., 1999) . This signal can be attenuated by the PI3K/AKT pathway (Berra et al., 1998) . Along the same line, the antiproliferative eect of IL-1 is mediated by p38 in the A375 melanoma cells (Itoh et al., 1999) . An example of an antiapoptotic eect of p38 is provided by Jurkat cells, where SB202190, which inhibits p38 and JNK, potentiated Fas (APO-1)-or UV-induced apoptosis (Nemoto et al., 1998) . Furthermore, protection of cells from TNFmediated cytotoxicity requires early activation of p38 (Roulston et al., 1998) . Like p38, JNK was shown to elicit either an anti-or a pro-apoptotic signal, depending on the type of cells and damage. For example, JNK can elicit a pro-apoptotic signal via upregulation of Fas ligand expression (Faris et al., 1998a,b) in response to various stimuli, including cisplatin (Sanchez-Perez and Perona, 1999) and UV-irradiation (Chen et al., 1996) .
The nature of these opposing signals may relate to their divergent eects on the same cellular targets. For example, JNK phosphorylates E2F and thus inhibits its activity whereas p38 reverses Rb-mediated repression of E2F1 . In other cases, stress kinases activate the same subset of substrates. UVirradiation, which eciently induces both JNK and p38, leads to phosphorylation and transcriptional activation of pro-and anti-apoptotic components including ATF2, c-Myc, Bcl2, c-Jun and p53 (Hsu et al., 1999; Fuchs et al., 1998; Yamamoto et al., 1999; Noguchi et al., 1999) . Investigation of mechanisms underlying the regulation of apoptosis has revealed the role of death receptors, including Fas, TNFR1, DR-3, TRAIL-R1 and TRAIL-R2, whose activity is selectively initiated upon interaction with their respective ligands (Ashkenazi and Dixit, 1998; Nagata, 1997) . Through their c-Jun and ATF2 substrates, p38 and JNK have been implicated in the regulation of major death-signaling cascades including Fas Ligand (FasL) transcription (Faris et al., 1998a,b; Kasibhatla et al., 1998) , as in the regulation of TNFa expression (Minden and Karin, 1997; Rhoades et al., 1992; Tsai et al., 1996) , suggesting that the balance between the stress kinases and their eectors is the key to understanding the regulation of the degree and nature of the apoptotic cascade. Since numerous observations point to a delicate balance between the stress-signaling components that are coordinated in a cell-type speci®c fashion, we further elucidated the regulation of UVinduced melanoma apoptosis by stress kinases.
In the present study we show that in melanoma cells p38 negatively regulates the expression of Fas. We demonstrate that this negative regulation is mediated via suppression of NF-kB transcriptional activity by the ASK1/p38 signaling pathway. The role ASK1/p38 plays in regulating the apoptotic pathway induced by UV-irradiation in melanoma cells through positive regulation of TNFa and negative regulation of Fas is discussed.
Results

MKK6/p38 protects whereas MKK7/JNK promotes cell death of UV-treated melanoma cells
As a ®rst step in assessing the role of ATF2 kinases in melanoma resistance to irradiation, we used upstream components of the JNK and p38 kinases, MKK7 and MKK6, respectively. Forced expression of these constructs in the melanoma LU1205 cells led to ecient phosphorylation of p38 ( Figure 1a) and JNK (not shown) and to a corresponding increase in the phosphorylation of the respective substrates c-Jun and ATF2 (not shown). Increase in phosphorylation of cJun and ATF2 is re¯ected in higher transcriptional activity directed by the 5xJun2tk-Luc reporter ( Figure  1b) , which is activated by Jun/ATF2 heterodimers (van Dam et al., 1998) . By contrast, p38-ASP, a dominant negative form of p38, eciently suppressed UVCinduced activity of 5xJun2tk-Luc (Figure 1b) . Cotransfection of MKK6-DD, a constitutive active form of MKK6, with GFP, as marker for transfected cells, allowed us to monitor the degree of death in the transfected cells.
Under these conditions, MKK6-DD (compared to an empty vector) caused a twofold decrease in the basal level of cell death and more than a 2.5-fold decrease in UV-treated cells (Figure 1c ), suggesting that MKK6 elicits protection of melanoma cells from UV-induced death. Indeed, forced expression of the dominant negative form of p38, p38-ASP led to more . After an additional 18 h, irradiated and untreated cells were analysed for luciferase and b-galactosidase activity. The normalized ratio of luciferase activity to b-galactosidase is shown. (c and d) UVC-induced death levels of LU1205 cells, which had been transiently transfected with GFP and MKK6-DD (0.25 and 1 mg, respectively) or GFP and p38-ASP, were determined using PI staining and¯ow-cytometric analysis. The ratio of GFP + PI + cells to the total number of GFP + cells indicates cell death levels for transfected cells than a 50% increase in the level of UV-induced cell death (Figure 1c) . In contrast to the eect of MKK6/ p38, MKK7 caused an 80% increase in the degree of cell death following UV-irradiation, whereas the dominant negative form of JNK, JNK-APF, abolished UV-mediated apoptosis (from 11 to 1.5%; Figure 1d ). These observations suggest that whereas MKK6 protects, MKK7 promotes death of UV-treated melanoma cells. These ®ndings are in line with our former studies revealing the role of transcriptionally active ATF2 in protection of melanoma cells from apoptosis and radiation resistance (Ivanov and Ronai, 1999) .
p38-elicited protection from cell death coincides with decreased Fas expression
To further elucidate the nature of p38-elicited protection of melanoma cells from cell death, we used the pharmacological inhibitor of p38 catalytic activity, SB203580 (Young et al., 1997) . Addition of the inhibitor 1 h before UV-irradiation of LU1205 cells decreased ATF2 phosphorylation (not shown) and transcriptional activity mediated by 5xJun2tk-Luc construct (Figure 2a ). Under the same conditions, inhibition of p38 led to a dose-dependent increase of up to fourfold in transcriptional activities mediated by NF-kB, about 3.5-fold in activation of Fas promoter and ®vefold in transcriptional activities mediated by FasL promoter (Figure 2a) . These results suggest that while suppressing ATF2 activities, inhibition of p38 increases NF-kB activities, Fas and FasL transcription, before as well as after UV-irradiation.
Similar to the eect of p38-ASP, the pharmacological inhibitor of p38 caused a dose-dependent increase (from 10 to 24%) in the fraction of cells that underwent apoptosis in response to UV-irradiation (Figure 2b ). Increase in UV-induced apoptosis coincided with an increase in surface Fas expression (Figure 2c ), which is the receptor of the prevailing apoptotic pathway upon UV-treatment of these melanoma cells (Ivanov and Ronai, 1999) . Surface expression of Fas, measured by mean¯uorescence intensity (MFI) representative of antigenic density on a per-cell basis, increased (from 95 to 121 MFI on a log scale) in SB203580-treated cells before ( Figure 2c ) and after (not shown) UV-treatment. These results suggest that p38 down-regulates Fas expression in a manner that coincides with protection of these melanoma cells from UV-induced death.
p38 suppression of Fas expression is mediated via the NF-kB/SP1 site on the Fas promoter
To further delineate the eect of p38 on Fas expression, we used nested deletions of the Fas promoter (Chan et al., 1999) . Co-expression of the 71.7 kb Fas promoterluciferase with MKK6-DD, a constitutively active form (Figure 3a) . MKK6-DD's ability to down-regulate Fas promoter activity was also seen with nested deletion of the Fas promoter (7306), but not with the 7259 or 7240 fragments (Figure 3a ). This suggests that a certain degree of suppression may be mediated through response elements that are located within the 7306/7259 domain which contain one of the three NF-kB sites within the Fas promoter (Chan et al., 1999) . Forced expression of dominant negative p38 caused 2 ± 3-fold increase in Fasmediated transactivation using the 7240 or 7259 Faspromoter-derived fragment, yet, a super-induction of Fas promoter activity was seen only with the 7306 fragment, which resulted in an over ninefold increase in Fas-Luc activity (Figure 3a ). These ®ndings suggest that the sequence within the 7306 fragment serves as the primary target for mediating suppression of Fas promoter activity. The latter domain contained the NF-kB/SP1 site (Chan et al., 1999) , suggesting that p38-mediated suppression is elicited through one of these target sequences.
The ability of dominant negative p38 to increase transactivation mediated by the Fas promoter ( Figure  3a ) is in agreement with the observation that p38 inhibition by SB203580 increased Fas expression (Figure 2a ,c).
To further elucidate the eect of p38 on NF-kB/SP1 target sequence, we used a reporter construct containing 6xNF-kB/SP1 sites obtained from Fas promoter (Chan et al., 1999) . Forced expression of p38-ASP caused a fourfold increase in 6xNF-kB/SP1-Luc activity, which further increased (eightfold) after UVirradiation (Figure 3b) . Mutation of the NF-kB/SP1 site of the Fas promoter (Chan et al., 1999) substantially decreased the promoter activity and abrogated the eect of p38-ASP (Figure 3c ).
Similar to the Fas promoter, the FasL promoter contained an SP1/NF-kB site, which is crucial for its activity (McClure et al., 1999; Hsu et al., 1999) . Forced expression of p38-ASP led to a marked increase in FasL-Luc activity, which was abrogated upon mutation in the SP1/NFAT/NF-kB sites at position 7288/ 7267 (Figure 3d) but not in the AP1/CREB site at position 7336/7330 (not shown). These observations suggest that p38 elicits suppression of FasL transcription through the NFAT/SP1/NF-kB site.
Inhibition of NF-kB down-regulates Fas and FasL expression and Fas-mediated apoptosis of UV-treated melanoma cells
To determine the relationship between p38's ability to suppress NF-kB to the silencing of Fas expression, we established LU1205 melanoma cells that stably express the super-repressor IkBDN (Figure 4a ). (Figure 4e ). This observation suggests that attenuating NF-kB activity sensitized LU1205 cells to TNFa mediated cell death. Further, antagonistic antibodies to TNFa also elicited a clear decrease in the level of UV-induced cell death in IkBDN but not in the parent LU1205 cells (not shown). These observations suggest that reduced NFkB activity aected the death signaling cascade and point to a delicate balance between TNFR-and Fassignaling pathways, which aects the nature and degree of UV-mediated apoptosis of these melanoma cells.
ASK1/p38 elicits suppression of Fas expression via downregulation of NF-kB activities
To further study p38/NF-kB relation to the regulation of Fas expression, we used the constitutively active forms of p38 upstream kinases MKK6-DD and ASK1DN. Forced expression of ASK1DN increased p38 phosphorylation (Figure 5a ) and led to a marked (13-fold) decrease in NF-kB promoter activities (Figure 5b ). Whereas JNK-APF, a dominant negative form of JNK, did not block ASK1-mediated inhibition of NF-kB transcriptional activities, p38-ASP was capable of attenuating some of this inhibition (from 13 to sixfold).
Similar to ASK1, MKK6-DD was also ecient in eliciting inhibition of NF-kB activities (4seven-fold), which were partially attenuated upon coexpression of p38-ASP (down to fourfold). Forced expression of p38-ASP eciently increased the level of NF-kB transcriptional activity (4threefold over the high basal level in these cells; Figure 5b ). Furthermore, forced expression of ASK1DN caused a dose-dependent decrease in promoter activities of Fas (Figure 5c ). Down-regulation of the Fas promoter could be attenuated upon forced expression of p38-ASP (Figure 5c ), further con®rming that suppression of the Fas promoter by ASK1 is mediated by p38.
To reveal mechanisms that underlie ASK1/MKK6 inhibition of NF-kB activities, we monitored the level of IkB phosphorylation, which directly re¯ects the availability of active NF-kB. Forced expression of ASK1DN reduced the level of IkB phosphorylation, which could be partially restored upon expression of p38-ASP (data not shown). Similarly, inhibition of p38 by the pharmacological inhibitor, or treatment with UV-irradiation, led to a twofold increase in the phosphorylation of IkB, monitored in solid phase kinase reaction. A further increase in phosphorylation of IkB of more than fourfold was observed upon cotreatment of UV and SB203580 (Figure 5d , upper panel). Increased IkB phosphorylation inversely correlated with the level of IkB expression, most likely due to increased degradation of phosphorylated IkB (Figure 5d , lower panel).
Low NF-kB activity and poor Fas expression coincides with high p38 activity in early-stage melanoma WM1552 cells
The relationship demonstrated in our studies for ASK1/p38 dependent NF-kB activity and Fas/FasL expression is exempli®ed in the human melanoma tumor WM1552-derived cells. This early-phase melanoma cell line exhibits low activity of JNK and NF-kB which were shown to be attributed to poor GCK expression (Ivanov et al., 2000) . The WM1552 cells possess poor NF-kB and Fas activities as re¯ected in the analysis of the respective promoters (not shown). Corresponding to the low levels of NF-kB and Fas promoter there is a relatively low expression of Fas cell surface protein, which is increased upon UV irradiation and furthermore (39 to 53 MFI) upon treatment with the pharmacological inhibitor of p38 (Figure 6a) . Similarly, expression of FasL is elevated in cells treated with the SB203580 inhibitor (Figure 6b ). Increase in Fas and FasL expression coincides with an increased level of cell death from 20 to 35% in UV-irradiated and SB203580-treated cells (Figure 6c ). Similarly, forced expression of p38 dominant negative construct increased level of apoptotic cells from 23 to 35% after UV-irradiation (Figure 6d ). This data provides an example for a relevant scenario of melanoma cells in which altered regulation of NF-kB and Fas could be attributed to p38 and is re¯ected in the sensitivity of these melanoma cells to undergo apoptosis in response to UV-irradiation.
Discussion
Unveiling mechanisms that underlie the resistance of melanoma to radiation and chemotherapy is important to the identi®cation of a means to better overcome this major clinical obstacle. In this study we identify a new regulatory pathway, which plays a key role in the regulation of Fas expression. Our data demonstrates that p38 elicits suppression of Fas expression in human melanoma cells, which is mediated by its inhibition of IkB phosphorylation and silencing of NF-kB. Weak activity of NF-kB and low expression of Fas are found to be ASK1/p38-dependent since inhibition of p38 activities was sucient to increase NF-kB activity, Fas/ FasL expression and the respective degree of apoptosis in response to UV-irradiation. Our studies also identify WM1552 early-phase melanoma cell line where this mechanism prevails, suggesting that p38-elicited downregulation of Fas expression is not restricted to latephase melanoma cells. Through its suppression of NFkB activity and Fas expression, p38 augments the upregulation of TNFa, which is mediated by its ATF2 eector. Given that TNFa and Fas comprise the balanced regulation of programmed cell death in human melanoma, up-regulation of TNFa in accordance with down-regulation of Fas, is expected to have a major impact on melanoma sensitivity to undergo apoptosis in response to external stimuli. Indeed, melanoma cells in which the Fas pathway represent the major death signaling and where TNFa elicits a survival signal, the combined eects of p38 through ATF2 and NF-kB is expected to decrease the degree of damage-induced death and thus confer resistance to such treatments. Our data directly supports this model ( Figure 7 ) which suggests that p38 plays a critical role in regulating melanoma's resistance to irradiation, and identi®es the mechanism by which p38 mediates this regulation. Although in the present study we have focused on two melanoma-derived cell lines, representing early and late phases in melanoma development, it is expected that p38 suppression of Fas via NF-kB will be also found in other melanomas as well as in dierent tumor types.
The ®nding that p38 can suppress NF-kB is supported by studies of p38's role in apoptosis of hematopoietic cells, in which the ability of the pharmacological inhibitor of p38 to block p38 mediated protection from apoptosis was associated with increased NF-kB activity (Birkenkamp et al., 1999) . Compounds that are known to stimulate p38, including sorbitol or sodium salicylate, eectively suppressed NF-kB activity, which could be reversed upon the expression of dominant negative p38 constructs or the addition of pharmacological inhibitors of p38 (Schwenger et al., 1997 (Schwenger et al., , 1998 . More recent studies point to the inhibition of IkB phosphorylation by p38, although the nature of this inhibition is not known (Alpert et al., 1999 ). Here we demonstrate that ASK1, an upstream regulator of the p38 pathway, mediates ecient suppression of Fas expression via inhibition of NF-kB activity. Further support for the relationship between UV-irradiation and NF-kB-dependent apoptosis is provided by ®nding that UVAirradiation decreases NF-kB activity in human keratinocytes (Djavaheri-Mergny et al., 1999) , and that increased apoptosis in skin requires inhibition of NFkB activity (Van Hogerlinden et al., 1999) .
In addition, the current studies determine that p38 also silences FasL expression. Suppresion of FasL is mediated through the SP1/NFAT/NF-kB site. Although we cannot exclude NFAT phosphorylation as a result of an indirect eect of p38 activity (Chow et al., 1997) , it is likely that reduced FasL promoter activity is also mediated via p38-mediated suppression of NF-kB activity. Coordinated NF-kB-dependent suppression of Fas and FasL is expected to cause ecient attenuation of Fas-mediated apoptosis. Indeed, suppression of p38 caused an increase in UV-induced, Fas-mediated, apoptosis. JNK may attenuate the suppressive eects of p38, as supported by the ®nding that JNK positively contributes to the expression of FasL (Faris et al., 1998a,b) , thereby antagonizing the eect of p38.
Previously reported data from other laboratories ± as well as from ours ± points to the role of p38/ATF2 in positively regulating TNFa expression (Ivanov and Ronai, 1999; Schafer et al., 1999; Cain et al., 1999) . The concordant roles of p38/NF-kB in the regulation of Fas vs TNF signaling is further illustrated by the observation that blocking NF-kB shifted UV-induced apoptosis from the Fas-mediated-cascade to the TNFmediated-cascade. Accordingly, through its inhibition of Fas/FasL and activation of TNF, ASK1/p38 and its transcription factor eectors emerge as an important regulator of apoptotic signaling in human melanoma cells (Figure 7) .
Other cellular regulatory pathways contribute to NF-kB activity, some of which may involve phosphorylation-independent degradation of IkB (Li and Karin, 1998) . Among other regulatory cascades is AKT/PKB, which was implicated in the regulation of IkB (Romashkova and Makarov, 1999; Ozes et al., 1999) . Analysis of PKB/AKT phosphorylation in the melanoma cells studied here did not reveal changes after UV-treatment. Other IKK regulatory components include NIK, TRIP or IRAK, which mediate TNF/ TRAF2-or IL1-inducing signals (Maniatis, 1999) . While expected to be cell type dependent, the nature of converged IkB regulation by multiple signaling pathways is a subject for intense investigation.
In summary, our ®ndings position p38 as a key regulator of TNF and Fas/FasL signaling in melanoma cells. These observations provide new understanding of the cellular determinants involved in the choice between TNF-and Fas-mediated cell death, and identify ASK1/p38 as a key regulatory component in dictating the nature and degree of UV-irradiationinduced apoptosis in this tumor type.
Materials and methods
Cell lines
Human melanoma LU1205 cells were maintained in MCDB153/L 15 medium (4 : 1) supplemented with 5% fetal bovine serum (FBS), L-glutamine and antibiotics. WM1552 are early-phase melanoma derived cells, which were maintained in the same medium supplemented with insulin (5 mg/ ml). LU1205/neo, and LU1205/IkBDN cell lines were maintained in the same medium supplemented with G418 (200 mg/ml). Cells were grown at 378C with 5% CO 2 . Figure 7 Model for the role of p38 in the regulation of apoptosis to UV-treated melanoma cells. Our previous studies have demonstrated the changes in TRAF2/GCK expression and activities during melanoma progression. Through the regulation of both p38 and JNK signaling TRAF2/GCK and their eectors p38/JNK kinases and ATF2/c-Jun transcription factors were implicated in melanoma sensitivity to radiation (Ivanov et al., 2000; Ivanov and Ronai, 1999; Ronai et al., 1998) . Data shown in the present study identi®es another layer of regulation, namely, the suppression of Fas expression upon p38 activation. This suppression is mediated via down-regulation of NF-kB activities that are p38-dependent. According to these observations activated p38 decreases the phosphorylation of IKK and NF-kB inhibitor. Whereas the mechanism underlying this decrease is yet to be elucidated, it results in the inhibition of NF-kB activity. Being important positive factor in the regulation of Fas and FasL expression, such suppression yields the decrease in Fas and FasL expression. In concordant with this suppression the p38 pathway eectively increases the activity of ATF2 and c-Jun which were implicated as positive factors in the regulation of TNFa expression. Given the antiapoptotic role of TNFa and the proapoptotic signal of Fas the change in Fas vs TNFa expression results in the increased sensitivity of the melanoma cells to radiation. It is expected that similar changes would take place in tumors where Fas and TNFa elicit negative and positive apoptotic signals, respectively Regulation of melanoma apoptosis by p38 VN Ivanov and Z Ronai
Stable transfection and selection
The expression vector pCMV4-IkBDN (Brockman et al., 1995) plus pcDNA3-neo was also co-transfected by electroporation (230 V, 1050 mF) into LU1205 cells as previously described . In parallel, pcDNA3-neo vector (Invitrogen, Carlsbad, CA, USA) was transfected to generate control LU1205-neo cells. LU1205/neo and LU1205/IkBDN cell lines were created as a mixed population of G418-resistant clones.
Transient transfection and luciferase assay
Transient transfection of dierent reporter constructs (0.25 ± 0.5 mg) together with quantities of expression vectors and pCMV-bgal (0.5 mg) into 5610 5 LU1205 melanoma cells was performed using Lipofectamine (Life Technologies-BRL). The reporter constructs used were: 2xNF-kB-Luc (Zandi et al., 1997) , 5xJun2tk-Luc, 5xTRE-tk-Luc and vector tk-Luc (van Dam et al., 1998) , 7615 TNF-Luc and 736 TNF-Luc (Rhoades et al., 1992) , 71.3 kb FasL-Luc (Kasibhatla et al., 1998) , 7453 FasL-Luc, 7318 FasL-Luc and their mutated variants (HoltzHeppelmann et al., 1998; McClure et al., 1999) , the Fas promoter constructs: 1.7 kb FPR1-Luc, D5, D5.7 D5.8, D6 and their mutated variants (Chan et al., 1999) . The expression constructs, pcDNA3-FLAG-MKK7b1 (Tournier et al., 1999) , pcDNA3-JNK1-APF (Butter®eld et al., 1997) p38-ASP (Enslen et al., 1998) MKK6-DD (Han et al., 1996) , and ASK1DN (Saitoh et al., 1998) were also used in these experiments. Luciferase activity was determined using the Luciferase assay system from Promega (Madison, WI, USA) and normalized based on b-galactosidase levels in transfected cells.
Transient transfection and GFP assay
Melanoma cells (5610 5 ) were transiently co-transfected with expression vectors together with marker plasmid encoding Green Fluorescent Protein (pGFP; 1 mg and 0.25 mg, respectively) using Lipofectamine (Life Technologies-BRL). Forty hours after transfection, cells were irradiated with UVC (60 J/m 2 ) and 18 h later were stained with propidium iodide (PI) and analysed by¯ow cytometry. The ratio of GFP + PI + /total GFP + cells was used to measure levels of cell death of transfected cells.
Treatment and apoptosis studies
Cells were exposed to UVC at 60 J/m 2 as previously described (2). Cycloheximide (10 mg/ml; Sigma, St. Louis, MO, USA) SB203580 (1 ± 10 mM; Calbiochem, San Diego, CA, USA) and recombinant TNFa (1 ± 10 ng/ml) (Pharmingen, San Diego, CA, USA) were used to treat melanoma cells. Antagonistic monospeci®c antibodies against Fas (clone G254 ± 274), against TNFa (clone Mab1 from Pharmingen, San Diego, CA, USA), and against TNFR1 (clone 16803.1 from R&D Systems, Minneapolis, MN, USA) were added as indicated at ®nal concentrations of 1 ± 5 mg/ml.
Annexin-V-FITC staining in the presence of PI was performed for detection of apoptosis levels using an Annexin-V-FITC kit (Pharmingen). Flow-cytometric analysis was performed on a FACScan or FACS Calibur¯ow cytometer (Becton Dickinson) using the Lysis II or CellQuest program, respectively. DNA fragmentation analysis was performed as described previously (Nicoletti et al., 1991) . Cells were pelleted and resuspended in 0.5 ml of hypotonic buer with 0.1% Triton X-100 containing PI (40 mg/ml) and DNase-free RNase A (1 mg/ml). Cells were incubated at 378C for 30 min and analysed on a¯ow cytometer (Becton Dickinson). The percentage of cells to the left of the diploid G 0/1 peak, characteristic of hypodiploid cells that have lost DNA, was calculated as the percentage of apoptotic cells. Analysis was performed without light scatter gating. Surface expression of Fas was determined using anti-Fas-PE Ab (Pharmingen) and¯ow-cytometric analysis.
Oligonucleotides and Electrophoretic Mobility Shift Assay (EMSA) Double-stranded oligonucleotides used in this study as speci®c probes for the transcription factor NF-kB, and the method used for the EMSA were described previously (Ivanov et al., 1995) . DNA-binding activities were quanti®ed using the BioRad Molecular Imaging system (model G5-250), equipped with Molecular Analysis software (BioRad, Hercules, CA, USA).
Western blot analysis
Cell lysates (50 ± 100 mg protein) were resolved on 10% SDS ± PAGE, transferred to nitrocellulose and processed according to the standard manual. The polyclonal Abs used were Phospho-MKK3/6 (Ser 189/207); Phospho-p38 (Thr180/ Tyr182); Phospho-ATF2 (Thr71) from New England BioLabs. Polyclonal anti-IkB (C-terminal) Abs were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Monoclonal anti-FasL Abs were obtained from Transduction Laboratories (Lexington, KY, USA). The primary Abs were used at dilutions 1 : 1000 ± 1 : 3000. The secondary Abs were anti-rabbit or anti-mouse IgG conjugated to horseradish peroxidase (dilution 1 : 5000). Signals were detected using the ECL system (Amersham, Arlington Heights, IL, USA).
Kinase assay
Protein kinase assays were carried out using fusion proteins, GST-IkBa, as a substrate as previously described (Adler et al., 1996) . Brie¯y, the GST-IkBa fusion protein (0.5 mg/assay) was bound to glutathione-sepharose beads after addition of melanoma proteins as the source of IKK (10 mg/assay) in the presence of kinase buer (20 mM HEPES, pH 7.6, 1 mM EGTA, 1 mM dithiothreitol, 2 mM MgCl 2 , 2 mM MnCl 2 , 5 mM NaF, 1 mM NaVO 3 , 50 mM NaCl) at room temperature for 15 min. The beads were pelleted and washed extensively with PBST (150 mM NaCl, 16 mM sodium phosphate, pH 7.5, 1% Triton X-100, 2 mM EDTA, 0.1% b-MeOH, 0.2 mM phenylmethylsulfonyl¯uoride, and 5 mM benzamidine) before incubation with [g-32 P]ATP (50 c.p.m./fmol; Amersham) in the presence of kinase buer. Following extensive washing, the phosphorylated GST-IkBa was boiled in SDS sample buer and the eluted proteins were run on a 15% SDS-polyacrylamide gel. The gel was dried and phosphorylation of the IkB substrate was determined by autoradiography, followed by quanti®ca-tion with a phosphorimager (BioRad).
Abbreviations AP1, activator protein-1; ASK1, apoptosis signal-regulating kinase 1; ATF2, activating transcription factor 2; FasL, Fas ligand; NF-kB, nuclear factor kappa B; PI, propidium iodide; TNFa, tumor necrosis factor alpha; TNFR, tumor necrosis factor receptor; TRAF2, tumor necrosis factor receptor associated factor 2; GFP, green¯uorescent protein; IkB, inhibitor NF-kB; IKK, IkB kinase; MAPK, mitogen-activated protein kinase; MFI, medium¯uores-cence intensity; MKK, MAPK kinase; CHX, cycloheximide; NFAT, nuclear factor of activated T lymphocytes.
